Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2013 Results
Date:5/9/2013

llion. The total revenues for the first quarter of 2013 and 2012 each included $1.5 million in Fanapt® royalties received from Novartis.

Total operating expenses for the first quarter of 2013 were $12.3 million, compared to $16.5 million for the first quarter of 2012.  The primary driver of the lower expenses in the first quarter of 2013 was the completion of the tasimelteon Non-24 and Major Depressive Disorder efficacy studies.

Vanda recorded a net loss of $4.2 million for the first quarter of 2013, compared to a net loss of $8.0 million for the same period in 2012.  Diluted net loss per share for the first quarter of 2013 was $0.15, compared to a diluted net loss per share of $0.28 for the first quarter of 2012.

Cash decreased by $9.5 million in the first quarter of 2013, compared to decreases of $10.6 million in the first quarter of 2012 and $14.0 million in the fourth quarter of 2012.  Vanda's Cash as of March 31, 2013 totaled $110.9 million.First Quarter 2013 Key Financial Figures1Three Months EndedMarch 31December 31(in thousands, except per share amounts)  20132012  Change ($)Change (%)Total revenues

$
8,068$
7,920$
482%Research & development  expenses

7,96010,617(2,657)(25%)General & administrative expenses

3,9583,22573323%Non-cash stock-based compensation2

952923293%Net loss

(4,173)(6,369)2,19634%Diluted net loss per share

$
(0.15)$
(0.23)$
.0835% Select Cash Flow Data1 Three Months EndedMarch 31March 31(in thousands)20132012Net cash provided by (used in)  Operating activities

$
(9,125)$
(8,690)  Investing activities

30,47728,861Financing activities

(193)- Select Balance Sheet Data1 March 31December 31March 31(in thousands)201320122012Total cash and marketable securities$
,932$
20,403$

'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
2. Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
3. Vanda Pharmaceuticals to Present at the Lazard Healthcare Conference
4. Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
5. Adamis Pharmaceuticals CEO Provides Update for Shareholders
6. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
7. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
8. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
9. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
10. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
11. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... BELLINGHAM, Washington, USA (PRWEB) September 30, 2014 ... complex yet efficient arrangements that have evolved in nature ... on biomimetic and bioinspired materials for applications in ... of Biomedical Optics . The journal is published by ... the SPIE Digital Library. Several of the peer-reviewed articles ...
(Date:10/1/2014)... LONDON, Sept. 30, 2014 This ... Enzymes in US$ Million by the following ... Specialty Enzymes. Specific end-use segments also analyzed ... The report provides separate comprehensive ... Asia-Pacific, Middle East, and Latin America. Annual ...
(Date:9/30/2014)... Using a bio-mimicking analog of one of nature,s ... international research team led by Alejandro Briseno of ... major step in developing long-sought polymer architecture to ... use in electronic devices. , Briseno, with ... others at Stanford University and Dresden University of ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Over the ... primarily due to rising R&D budgets and increased acceptance ... fast growing pharmaceutical and biotechnology industries are also catalyzing ... laboratory filtration market is expected to grow at a ... is estimated to be worth $2,532.6 million by 2019. ...
Breaking Biology Technology:Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 2Biomimetic and bioinspired materials enable new healthcare options, reports Journal of Biomedical Optics 3Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24Global Specialty Enzymes Industry 25Global Specialty Enzymes Industry 26Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5
... Calif., Oct. 8 KineMed Inc., a privately,held pathway-based ... Fineman, CEO and President of KineMed, will present an,overview ... the 4th Annual,BIO Investor Forum in San Francisco on ... Heights room of the Palace Hotel. Mr. Fineman will,provide ...
... 7 Protalix,BioTherapeutics, Inc. (Amex: PLX ), ... public offering of its common stock pursuant to ... The company is proposing to sell 3,726,708 shares ... proposing to sell an,aggregate of 1,242,236 shares of ...
... President, Research Operations - Dr. ... CARLSBAD, Calif., Oct. 5 Ardea Biosciences,Inc. ... the discovery and,development of small-molecule therapeutics for the ... announced changes to its,research management. Dr. Jean-Luc Girardet ...
Cached Biology Technology:KineMed to Present at the 4th Annual BIO Investor Forum 2Protalix BioTherapeutics Announces Public Offering of Common Stock 2Protalix BioTherapeutics Announces Public Offering of Common Stock 3Ardea Biosciences Announces Changes to Research Management 2Ardea Biosciences Announces Changes to Research Management 3
(Date:9/30/2014)... 30, 2014  Spectra Automation, a trusted ... biotech and power generation industries, announced today ... Manager, an easy-to-use and cost-effective data collection, ... development laboratories. Most upstream ... analyzer systems. Accessing and consolidating data from ...
(Date:9/30/2014)... 2014) People who suffer from asthma may think ... their asthma besides properly taking medications and avoiding allergic ... the Annals of Allergy, Asthma and Immunology , ... Asthma and Immunology (ACAAI), asthma sufferers can learn lessons ... woman described in the Annals article improved her asthma ...
(Date:9/29/2014)... ramosum , coupled with a high-fat diet, may cause animals ... mBio , the online open-access journal of the American ... German Institute of Human Nutrition Potsdam-Rehbruecke in Nuthetal observed that ... gained weight when fed a high-fat diet. Mice that did ... when consuming a high-fat diet, and mice that had ...
Breaking Biology News(10 mins):Spectra Automation Introduces RECONN Bioprocess Manager 2Asthma symptoms kicking up? Check your exposure to air pollution 2Gut bacteria promote obesity in mice 2
... previous work with engines traveling on straight tracks, a ... of Oxford have successfully used DNA building blocks to ... of tracks with multiple switches. The findings, published in ... Nature Nanotechnology , are expected to lead to further ...
... at the RIKEN SPring-8 Center in Harima, Japan have ... reductase (qNOR), a bacterial enzyme that offers clues on ... to their importance to fundamental science, the findings provide ... ozone-depleting and greenhouse gas hundreds of times more potent ...
... San Diego Zoo Institute for Conservation Research scientists shows ... condor in the wild are human influenced, with lead ... birds. , The study documents the deaths of ... Baja, California, Mexicofrom the inception of the reintroduction program ...
Cached Biology News:New study sheds light on evolutionary origin of oxygen-based cellular respiration 2Scientific paper shows California condor still threatened by human activities 2
... tissue extracts (liver, kidney, spleen, and heart) and ... It was also tested with microsomal fractions prepared ... simple and reliable method for measuring NDPase activity ... the inorganic phosphate released from NDP by the ...
... Principle: The sulfidoleukotrienes ... are products of arachidonic acid ... In the past, they were ... of Anaphylaxis (SRS-A)". They are ...
... the condition in which a lack of ... the various antioxidants. Oxidative stress appears ... several diseases, including artherosclerosis, chronic inflammatory diseases, ... antioxidant systems that are very important for ...
... Compound(s) tested through 63 ... assays spanning a broad ... panel includes many non ... several non-selective assays. ...
Biology Products: